Bruker Corporation - Asset Resilience Ratio

Latest as of June 2024: 0.22%

Bruker Corporation (BRKR) has an Asset Resilience Ratio of 0.22% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See BRKR working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$12.70 Million
Cash + Short-term Investments

Total Assets

$5.90 Billion
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2000–2023)

This chart shows how Bruker Corporation's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Bruker Corporation asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down Bruker Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read total liabilities of Bruker Corporation for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $12.70 Million 0.22%
Total Liquid Assets $12.70 Million 0.22%

Asset Resilience Insights

  • Limited Liquidity: Bruker Corporation maintains only 0.22% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Bruker Corporation Industry Peers by Asset Resilience Ratio

Compare Bruker Corporation's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Demant A/S
CO:DEMANT
Medical Devices -2.59%
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Vitrolife AB
ST:VITR
Medical Devices 7.27%
Tellgen Corp
SHE:300642
Medical Devices 12.10%
Imricor Medical Systems Inc
AU:IMR
Medical Devices 46.50%
Hironic Co. Ltd
KQ:149980
Medical Devices 17.42%
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%

Annual Asset Resilience Ratio for Bruker Corporation (2000–2023)

The table below shows the annual Asset Resilience Ratio data for Bruker Corporation.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 0.28% $12.00 Million $4.25 Billion -2.49pp
2022-12-31 2.77% $100.00 Million $3.61 Billion +0.03pp
2021-12-31 2.74% $100.00 Million $3.65 Billion +1.10pp
2020-12-31 1.64% $50.00 Million $3.05 Billion +1.40pp
2019-12-31 0.24% $6.60 Million $2.77 Billion --
2018-12-31 0.00% $0.00 $2.13 Billion --
2017-12-31 5.86% $114.20 Million $1.95 Billion -2.85pp
2016-12-31 8.71% $157.90 Million $1.81 Billion -2.91pp
2015-12-31 11.62% $201.20 Million $1.73 Billion +2.08pp
2014-12-31 9.55% $178.00 Million $1.86 Billion +9.41pp
2013-12-31 0.14% $2.70 Million $1.99 Billion -0.06pp
2012-12-31 0.20% $3.70 Million $1.86 Billion +0.07pp
2011-12-31 0.13% $2.20 Million $1.71 Billion -0.06pp
2010-12-31 0.19% $2.90 Million $1.55 Billion +0.02pp
2009-12-31 0.17% $2.00 Million $1.17 Billion +0.04pp
2008-12-31 0.13% $1.50 Million $1.12 Billion -12.73pp
2005-12-31 12.86% $46.42 Million $360.89 Million +0.71pp
2004-12-31 12.15% $45.14 Million $371.55 Million +8.11pp
2003-12-31 4.04% $14.20 Million $351.03 Million -3.22pp
2002-12-31 7.26% $14.75 Million $203.10 Million -25.40pp
2001-12-31 32.66% $61.75 Million $189.07 Million -6.84pp
2000-12-31 39.50% $72.89 Million $184.55 Million --
pp = percentage points

About Bruker Corporation

NASDAQ:BRKR USA Medical Devices
Market Cap
$9.77 Billion
Market Cap Rank
#3217 Global
#1133 in USA
Share Price
$64.18
Change (1 day)
+0.28%
52-Week Range
$30.88 - $64.34
All Time High
$94.13
About

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, ser… Read more